G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 12, 2026, 10:39 AM EST

GMVDF Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Net Income
-13.52-14.46-12.54-15.01-16.26
Depreciation & Amortization
1.211.361.422.872.68
Loss (Gain) From Sale of Assets
0.440.020.58-0.01
Asset Writedown & Restructuring Costs
--2.84-0.42
Stock-Based Compensation
12.490.652.871.560.21
Other Operating Activities
-19.62-0.64-0.860.15-1.55
Change in Accounts Receivable
-0.090.21-0.160.15-0.27
Change in Inventory
-2.02-0.270.290.98-1.12
Change in Accounts Payable
2.32-1.740.740.941.03
Change in Other Net Operating Assets
0.33.370.182.44-0.6
Operating Cash Flow
-18.48-11.49-4.65-6.3-15.46
Capital Expenditures
-2.12-0.55-0.51-0.43-2.37
Sale of Property, Plant & Equipment
0.030.07--0.09
Cash Acquisitions
-----1.92
Other Investing Activities
-0.040.470.05--0.66
Investing Cash Flow
-2.12-0.02-0.46-0.43-4.86
Short-Term Debt Issued
1-0.144.985.57
Long-Term Debt Issued
14.855.841.221.343.9
Total Debt Issued
15.855.841.376.329.47
Short-Term Debt Repaid
--0.27-0.09--
Long-Term Debt Repaid
-6.31-1.72-4.89-2.22-1.59
Total Debt Repaid
-6.31-1.99-4.98-2.22-1.59
Net Debt Issued (Repaid)
9.543.85-3.614.17.88
Issuance of Common Stock
5.4413.428.99-0.97
Repurchase of Common Stock
-0.12----
Financing Cash Flow
14.8617.275.384.18.85
Foreign Exchange Rate Adjustments
----0.01-0.06
Net Cash Flow
-5.745.760.28-2.63-11.52
Free Cash Flow
-20.6-12.04-5.15-6.73-17.82
Free Cash Flow Margin
-466.06%-242.77%-105.18%-121.72%-582.00%
Free Cash Flow Per Share
-28.58-37.12-24.54-54.68-162.47
Cash Interest Paid
00.140.560.140.21
Cash Income Tax Paid
0.02--00.04
Levered Free Cash Flow
-4.87-6.22-3.13-2.07-11.2
Unlevered Free Cash Flow
-2.32-5.71-2.84-1.19-10.58
Change in Working Capital
0.521.571.034.14-0.96
Updated May 16, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.